These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 28615088)

  • 41. Imipenemase-producing carbapenem-resistant Enterobacteriaceae transmission in a long-term-care facility during a community-wide multidrug resistant organism outbreak-North Carolina, 2017.
    Dubendris H; MacFarquhar J; Kornegay R; Gable P; Boyd S; Walters M; Greene S
    Am J Infect Control; 2020 Mar; 48(3):320-323. PubMed ID: 31331713
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Carbapenem-resistant Enterobacteriaceae carriers in acute care hospitals and postacute-care facilities: The effect of organizational culture on staff attitudes, knowledge, practices, and infection acquisition rates.
    Fedorowsky R; Peles-Bortz A; Masarwa S; Liberman D; Rubinovitch B; Lipkin V
    Am J Infect Control; 2015 Sep; 43(9):935-9. PubMed ID: 26116334
    [TBL] [Abstract][Full Text] [Related]  

  • 43. How Introducing a Registry With Automated Alerts for Carbapenem-resistant Enterobacteriaceae (CRE) May Help Control CRE Spread in a Region.
    Lee BY; Bartsch SM; Hayden MK; Welling J; DePasse JV; Kemble SK; Leonard J; Weinstein RA; Mueller LE; Doshi K; Brown ST; Trick WE; Lin MY
    Clin Infect Dis; 2020 Feb; 70(5):843-849. PubMed ID: 31070719
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Population-based incidence of carbapenem-resistant Klebsiella pneumoniae along the continuum of care, Los Angeles County.
    Marquez P; Terashita D; Dassey D; Mascola L
    Infect Control Hosp Epidemiol; 2013 Feb; 34(2):144-50. PubMed ID: 23295560
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Epidemiology of Carbapenem-resistant Enterobacteriaceae in Egyptian intensive care units using National Healthcare-associated Infections Surveillance Data, 2011-2017.
    Kotb S; Lyman M; Ismail G; Abd El Fattah M; Girgis SA; Etman A; Hafez S; El-Kholy J; Zaki MES; Rashed HG; Khalil GM; Sayyouh O; Talaat M
    Antimicrob Resist Infect Control; 2020; 9(1):2. PubMed ID: 31911830
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The SHIELD Orange County Project: Multidrug-resistant Organism Prevalence in 21 Nursing Homes and Long-term Acute Care Facilities in Southern California.
    McKinnell JA; Singh RD; Miller LG; Kleinman K; Gussin G; He J; Saavedra R; Dutciuc TD; Estevez M; Chang J; Heim L; Yamaguchi S; Custodio H; Gohil SK; Park S; Tam S; Robinson PA; Tjoa T; Nguyen J; Evans KD; Bittencourt CE; Lee BY; Mueller LE; Bartsch SM; Jernigan JA; Slayton RB; Stone ND; Zahn M; Mor V; McConeghy K; Baier RR; Janssen L; O'Donnell K; Weinstein RA; Hayden MK; Coady MH; Bhattarai M; Peterson EM; Huang SS
    Clin Infect Dis; 2019 Oct; 69(9):1566-1573. PubMed ID: 30753383
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The spread of carbapenem-resistant Enterobacteriaceae in South Africa: risk factors for acquisition and prevention.
    Brink A; Coetzee J; Clay C; Corcoran C; van Greune J; Deetlefs JD; Nutt L; Feldman C; Richards G; Nordmann P; Poirel L
    S Afr Med J; 2012 May; 102(7):599-601. PubMed ID: 22748433
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Carbapenem-Resistant Enterobacteriaceae Transmission in Health Care Facilities - Wisconsin, February-May 2015.
    Elbadawi LI; Borlaug G; Gundlach KM; Monson T; Warshauer D; Walters MS; Kallen A; Gulvik CA; Davis JP
    MMWR Morb Mortal Wkly Rep; 2016 Sep; 65(34):906-9. PubMed ID: 27584864
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Carbapenem-Resistant Enterobacteriaceae: A Strategic Roadmap for Infection Control.
    Friedman ND; Carmeli Y; Walton AL; Schwaber MJ
    Infect Control Hosp Epidemiol; 2017 May; 38(5):580-594. PubMed ID: 28294079
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Carbapenem-Resistant Enterobacteriaceae in Children, United States, 1999-2012.
    Logan LK; Renschler JP; Gandra S; Weinstein RA; Laxminarayan R; ;
    Emerg Infect Dis; 2015 Nov; 21(11):2014-21. PubMed ID: 26486124
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Carbapenem-resistant Enterobacteriaceae in sink drains of 40 healthcare facilities in Sindh, Pakistan: A cross-sectional study.
    Apanga PA; Ahmed J; Tanner W; Starcevich K; VanDerslice JA; Rehman U; Channa N; Benson S; Garn JV
    PLoS One; 2022; 17(2):e0263297. PubMed ID: 35113948
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Active surveillance of carbapenem-resistant Enterobacteriaceae in intensive care units: Is it cost-effective in a nonendemic region?
    Ho KW; Ng WT; Ip M; You JH
    Am J Infect Control; 2016 Apr; 44(4):394-9. PubMed ID: 26698671
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Epidemiology of carbapenem-resistant Enterobacteriaceae in hospitals of a large healthcare system in Miami, Florida from 2012 to 2016: Five years of experience with an internal registry.
    Jimenez A; Trepka MJ; Munoz-Price LS; Pekovic V; Ibrahimou B; Abbo LM; Martinez O; Sposato K; dePascale D; Perez-Cardona A; McElheny CL; Bachman WC; Fowler EL; Doi Y; Fennie K
    Am J Infect Control; 2020 Nov; 48(11):1341-1347. PubMed ID: 32334004
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Molecular and descriptive epidemiologyof multidrug-resistant Enterobacteriaceae in hospitalized infants.
    Anderson B; Nicholas S; Sprague B; Campos J; Short B; Singh N
    Infect Control Hosp Epidemiol; 2008 Mar; 29(3):250-5. PubMed ID: 18251685
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evaluating Movement of Patients With Carbapenem-resistant Enterobacteriaceae Infections in the Greater Atlanta Metropolitan Area Using Social Network Analysis.
    Bower CW; Fridkin DW; Wolford HM; Slayton RB; Kubes JN; Jacob JT; Ray SM; Fridkin SK
    Clin Infect Dis; 2020 Jan; 70(1):75-81. PubMed ID: 30809636
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Asymptomatic colonization with carbapenem resistant enterobacteriaceae (CRE) in ICU patients and its associated risk factors: Study from North India.
    Datta P; Gupta V; Singla N; Chander J
    Indian J Med Microbiol; 2015; 33(4):612-3. PubMed ID: 26470985
    [No Abstract]   [Full Text] [Related]  

  • 57. Evaluation of carbapenem resistance using phenotypic and genotypic techniques in Enterobacteriaceae isolates.
    Sahin K; Tekin A; Ozdas S; Akin D; Yapislar H; Dilek AR; Sonmez E
    Ann Clin Microbiol Antimicrob; 2015 Oct; 14():44. PubMed ID: 26444537
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Carbapenem-resistant enterobacteriaceae: an emerging problem in children.
    Logan LK
    Clin Infect Dis; 2012 Sep; 55(6):852-9. PubMed ID: 22700827
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Development of a Nomogram for Carbapenem-Resistant Enterobacteriaceae Acquisition Risk Prediction Among Patients in the Intensive Care Unit of a Secondary Referral Hospital.
    Seo SM; Jeong IS; Song JY; Lee S
    Asian Nurs Res (Korean Soc Nurs Sci); 2021 Aug; 15(3):174-180. PubMed ID: 33621701
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Ertapenem resistance in 2 tertiary-care hospitals: Microbiology, epidemiology, and risk factors.
    Maldonado N; Castro B; Berrio I; Manjarrés M; Robledo C; Robledo J
    Enferm Infecc Microbiol Clin; 2017 Oct; 35(8):511-515. PubMed ID: 26778651
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.